CAS: 985-12-6 - Drotaverine hydrochloride
Formula:C24H31NO4·ClH
InChI:InChI=1S/C24H31NO4.ClH/c1-5-26-21-10-9-17(14-22(21)27-6-2)13-20-19-16-24(29-8-4)23(28-7-3)15-18(19)11-12-25-20;/h9-10,13-16,25H,5-8,11-12H2,1-4H3;1H
InChI key:InChIKey=JBFLYOLJRKJYNV-UHFFFAOYSA-N
SMILES:Cl.O(C1=CC=C(C=C1OCC)C=C2NCCC3=CC(OCC)=C(OCC)C=C23)CC
- Synonyms:
- (1E)-1-[(3,4-diethoxyphenyl)methylidene]-6,7-diethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride
- 1,2,3,4-Tetrahydro-6,7-diethoxy-1-((3,4-diethoxyphenyl)methylene)-isoquinoline hydrochloride
- 1-(3,4-Diethoxy-benzylidene)-6,7-diethoxy-1,2,3,4-tetrahydro-isoquinoline; hydrochloride
- Drotaverin hydrochloride
- Drotaverine hcl
- Drotaverinium chloride
- Drotin
- Isodihydroperparine hydrochloride
- Isoquinoline, 1-(3,4-diethoxybenzylidene)-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride
- Isoquinoline, 1-[(3,4-diethoxyphenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride
- See more synonyms
- Isoquinoline, 1-[(3,4-diethoxyphenyl)methylene]-6,7-diethoxy-1,2,3,4-tetrahydro-, hydrochloride (1:1)
- No-Spa
- No-Spa hydrochloride
- Nosh-Bra
- Tetraspasmin-Lefa
Drotaverine Hydrochloride
CAS:985-12-6
Formula:
C24H32ClNO4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
433.9682
Ref: IN-DA006RWE
10mg | 201.00 € | ||
25mg | 659.00 € | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
Drotaverine hydrochloride
CAS:985-12-6
Formula:
C24H31NO4
Purity:
≥ 95%
Color and Shape:
White to off-white or yellow powder
Molecular weight:
397.51
Ref: 7W-GP2082
10mg | 102.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Ref: 4Z-D-088001
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Drotaverine Hydrochloride
CAS:985-12-6
Formula:
C24H31NO4·HCl
Purity:
>95.0%(T)(HPLC)
Color and Shape:
White to Light orange to Pale yellow green powder to crystal
Molecular weight:
433.97
Ref: 3B-D6205
1g | 379.00 € | ||
200mg | 111.00 € |
Estimated delivery in United States, on Thursday 19 Dec 2024
Drotaverine hydrochloride
CAS:985-12-6
Drotaverine hydrochloride is a type 4 cyclic nucleotide phosphodiesterase (PDE4) inhibitor,and is an antispasmodic drug, …
Formula:
C24H32ClNO4
Purity:
99.81%
Color and Shape:
Pale-Yellow Crystalline Solid
Molecular weight:
433.968
Ref: TM-T8787
5mg | 51.00 € | ||
10mg | 78.00 € | ||
25mg | 134.00 € | ||
50mg | 245.00 € | ||
100mg | 365.00 € | ||
500mg | 875.00 € | ||
1mL*10mM (DMSO) | 57.00 € |
Estimated delivery in United States, on Monday 23 Dec 2024
Ref: 10-F979071
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Friday 27 Dec 2024
Drotaverine Hydrochloride
Controlled ProductCAS:985-12-6
Applications Analogue of Papaverine. Antispasmodic. References Lalla, J., et al.: J. Pharm. Biomed. Anal., 11, …
Formula:
C24H31NO4·ClH
Color and Shape:
Neat
Molecular weight:
433.97
Ref: TR-D689700
10mg | 236.00 € | ||
50mg | 977.00 € | ||
100mg | 1,585.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Drotaverine HCl - Bio-X ™
CAS:985-12-6
Drotaverine is an antispasmodic drug that is used to alleviate gastrointestinal and genitourinary smooth muscle …
Formula:
C24H31NO4•HCl
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
433.97 g/mol
Ref: 3D-BD164396
10mg | 138.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Drotaverine hydrochloride
CAS:985-12-6
Phosphodiesterase 4 inhibitor; anti-spasmodic agent
Formula:
C24H32ClNO4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
433.97 g/mol
Ref: 3D-FD22624
1g | 633.00 € | ||
2g | 1,025.00 € | ||
5g | 1,607.00 € | ||
250mg | 272.00 € | ||
500mg | 410.00 € |
Estimated delivery in United States, on Friday 27 Dec 2024
Drotaverine-d10 Hydrochloride
Controlled ProductCAS:985-12-6
Formula:
C24H22D10ClNO4
Color and Shape:
Neat
Molecular weight:
444.03
Ref: TR-D689702
100mg | 9,017.00 € |
Estimated delivery in United States, on Tuesday 28 Jan 2025